Stevens-Johnson syndrome and herpes simplex reactivation associated with paracetamol use. Case report
Síndrome de Stevens-Johnson con reactivación de herpes simple asociado a la ingesta de paracetamol. Reporte de caso
DOI:
https://doi.org/10.15446/revfacmed.v69n4.85264Palabras clave:
Stevens-Johnson Syndrome, Herpes Simplex, Acetaminophen, Erythema Multiforme, Drug Eruptions, Colombia (en)Síndrome de Stevens-Johnson, Herpes simple, Acetaminofén, Eritema multiforme, Erupciones por medicamentos, Colombia (es)
Descargas
Introduction: Stevens-Johnson syndrome (SJS) is a rare disease that affects the skin, as well as the oral, ocular, and urogenital mucous membranes. This condition is caused by drug reactions in more than 50% of cases.
Case presentation: A 20-year-old male visited the emergency service of a tertiary care hospital of Popayán due to a 10-day history of asthenia, adynamia, fever (without objective measurement records), cough with scarce whitish sputum, and headache that improved with paracetamol treatment. However, his condition worsened in the last two days, and he developed hyporexia, pharyngeal pruritus, vesicles, and blisters on the corners of the mouth, the oral mucosa, the trunk, and limbs, as well as breathing difficulty and odynophagia, prompting him to seek medical treatment at the ER. At first, disseminated herpes simplex, systemic lupus erythematosus and SJS were suspected, but based on clinical and laboratory findings, the patient was finally diagnosed with SJS with herpes simplex reactivation associated with the use paracetamol. Consequently, the administration of this drug was stopped and management with acyclovir and methylprednisolone was started. The patient progressed satisfactorily and was discharged 10 days after beginning the new treatment, and his general condition was optimal during follow-up appointments.
Conclusion: The occurrence of SJS may be associated with the oral administration of paracetamol; nevertheless, its use is not discouraged due to its great overall benefits. In this sense, given that paracetamol is an over-the-counter drug widely used in Colombia, recognizing the clinical manifestations of SJS is essential to provide adequate management and avoid complications in cases such as the one reported here.
Introducción. El síndrome de Stevens-Johnson (SJS) es una enfermedad poco común que afecta la piel y las mucosas oral, ocular y urogenital; además, en más del 50% de los casos es producida por reacciones a medicamentos.
Presentación del caso. Hombre de 20 años quien asistió al servicio de urgencias de un hospital de tercer nivel de Popayán (Colombia) por un cuadro clínico de 10 días de evolución consistente en astenia, adinamia, fiebre no cuantificada, tos con escasa expectoración blanquecina y cefalea, sintomatología que mejoraba con el uso de paracetamol; sin embargo, la condición del paciente empeoró en los últimos dos días, presentando hiporexia, prurito en faringe, vesículas y ampollas en comisuras labiales, mucosa oral, tronco y extremidades, además de dificultad respiratoria y odinofagia, razón por la cual acudió al servicio. En principio de sospechó de herpes simple diseminado, lupus eritematoso sistémico, y SJS; sin embargo, con base en los hallazgos clínicos y de laboratorio se confirmó el diagnóstico de SJS con reactivación de herpes simple asociado a la ingesta de paracetamol, por lo que se suspendió este medicamento y se inició manejo con aciclovir y metilprednisolona. El paciente tuvo una evolución satisfactoria y fue dado de alta a los 10 días del inicio del nuevo tratamiento y en las citas de control su condición general era óptima.
Conclusiones. El desarrollo de SJS puede estar asociado al consumo de paracetamol; sin embargo, su uso no se desaconseja gracias a sus grandes bondades y beneficios generales. En este sentido, dado que el paracetamol es un medicamento de venta libre y uso extenso en Colombia, es indispensable reconocer las manifestaciones clínicas del SJS para poder dar un manejo adecuado y evitar complicaciones en casos como el aquí reportado.
Referencias
Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5(1):39. https://doi.org/d24sr6.
French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int. 2006;55(1):9-16. https://doi.org/cs6h7n.
Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7(6):803-13. https://doi.org/bzkn7p.
Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138(8):1019-24. https://doi.org/ds5qqk.
Jung JW, Kim JY, Park IW, Choi BW, Hang HR. Genetic markers of severe cutaneous adverse reactions. Korean J Intern Med. 2018;33(5):867-75. https://doi.org/gdqmwh.
Chen CB, Abe R, Pan RY, Wang CW, Hung SI, Tsai YG, et al. An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity. J Immunol Res. 2018;2018:6431694. https://doi.org/gc988z.
Fan WL, Shiao MS, Hui RCY, Su SC, Wang CW, Chang YC, et al. HLA Association with Drug-Induced Adverse Reactions. J Inmmunol Res. 2017;2017:3186328. https://doi.org/g6f4.
White KD, Chung WH, Hung SI, Mallal S, Phillips EJ. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. J Allergy Clin Immunol. 2015;136(2):219-34. https://doi.org/f3hc69.
Su SC, Chung WH. Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis. Dermatologica Sin. 2013;31(4):175-80. https://doi.org/g6f5.
Su SC, Hung SI, Fan WL, Dao RL, Chung WH. Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation. Int J Mol Sci. 2016;17(11):1890. https://doi.org/g6f6.
Okamoto-Uchida Y, Nakamura R, Sai K, Imatoh T, Matsunaga K, Aihara M, et al. Effect of Infectious Diseases on the Pathogenesis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Biol Pharm Bull. 2017;40(9):1576-80. https://doi.org/gbxc5m.
Torres M, Olmos E. Reacciones medicamentosas severas: Síndrome Stevens Johnson y síndrome DRESS. Acta Med Colomb. 2013;38(2):76-82. https://doi.org/g6f8.
Victoria Chaparro J. Eritema multiforme. In: Falabella-Falabella R, Victoria-Chaparro J, Barona-Cabal MI. Fundamentos de medicina: Dermatología. 8th ed. Medellín: Corporación para Investigaciones Biológicas, CIB; 2017.
Lazar JF, Muphy GF. La piel. In: Kumar V, Abbas AK, Fausto N, Aster J. Robbins y Cotran. Patología estructural y funcional. 8th ed. Barcelona: Elsevier Saunders; 2010.
Domínguez- Domínguez C, Bonilla-Briceño JF, Buitrago-Marín C, Calderón-Ospina CA. Síndrome de Stevens-Johnson asociado a fenitoína en una paciente colombiana con síndrome convulsivo focal. Médicas UIS. 2012;25(2):155-62.
Chantaphakul H, Sanon T, Klaewsongkram J. Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Ther Med. 2015;10(2):519-24. https://doi.org/ghwcgb.
Miura S, Smith CC, Burnett JW, Aurelian L. Detection of Viral DNA Within Skin of Healed Recurrent Herpes Simplex Infection and Erythema Multiforme Lesions. J Invest Dermatol. 1992;98(1):68-72. https://doi.org/bnp7zq.
Neuman MG, McKinney KK, Nanau RM, Kong V, Malkiewicz I, Mazulli T, et al. Drug.induced severe adverse reaction enhanced by human herpes virus-6 reactivation. Transl Res. 2013;161(5):430-40. https://doi.org/g6gg.
Brice SL, Krzemien D, Weston WL, Huff JC. Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol. 1989;93(1):183-7. https://doi.org/frfcb8.
Shiohara T. The role of viral infection in the development of severe drug eruptions. Dermatologica Sin. 2013;31(4):205-10. https://doi.org/g6gh.
Ishida T, Kano Y, Mizukawa Y, Shiohara T. The dynamics of herpesvirus reactivation during and after severe drug eruptions. Allergy. 2014;69(6):798-805. https://doi.org/gcbrd3.
Abrouk M, Song JE, Linden KG. A recalcitrant case of toxic epidermal necrolysis. Cutis. 2018;101(3):E8-10.
Irungu K, Nyamu D, Opanga S. Characterization of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to Kenyatta National Hospital: A Retrospective Cross-Sectional Study. Drugs Real World Outcomes. 2017;4(2):79-85. https://doi.org/g6gk.
U.S. Food and Drug Administration (FDA) [Internet]. Silver Spring: FDA; 2016 [cited 2020 Apr 10]. FDA Drug Safety Communication: FDA warns of rare but serious skin reactions with the pain reliever/fever reducer acetaminophen Available from: https://bit.ly/3nIRG9R.
Pena MA, Pérez S, Zazo MC, Alcalá PJ, Cuello JD, Zapater P, et al. A Case of Toxic Epidermal Necrolysis Secondary to Acetaminophen in a Child. Curr Drug Saf. 2016;11(1):99-101. https://doi.org/g6gm.
Biswal S, Sahoo SS. Paracetamol induced Stevens-Johnson syndrome - toxic epidermal necrolysis overlap syndrome. Int J Dermatol. 2014;53(8):1042-4. https://doi.org/f6hw84.
Kim EJ, Lim H, Park SY, Kim S, Yoon SY, Bae YJ, et al. Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen. Asia Pac Allergy. 2014;4(1):68-72. https://doi.org/gb93fs.
Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes-Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study. J Invest Dermatol. 2008;128(1):35-44. https://doi.org/dwqc5q.
Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: A severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115(2):149-53. https://doi.org/dbkn9q.
Santa-Vélez C, Morales N, Calle J, Márquez JD, Pinto-Peñaranda LF, Velásquez CJ. Necrólisis epidérmica tóxica y lupus eritematoso sistémico. Rev CES Med. 2018;32(1):67-73. https://doi.org/g6gp.
Vázquez-Sanabria IL, Mercado-Seda R, Varela-Rosario N, Vilá LM. Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome. BMJ Case Rep. 2015;2015: bcr2015211157. https://doi.org/g6gq.
Torchia D, Romanelli P, Kerdel FA. Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythemarosus. J Am Acad Dermatol. 2012;67(3):417-21. https://doi.org/fhqr7n.
Rincón-Riaño DN, Fernández-Ávila DG, Gutiérrez JM. Síndrome de Stevens Johnson inducido por leflunomida en un paciente con lupus eritematoso sistémico. Rev Colomb Reumatol. 2017;24(4):242-6. https://doi.org/g6gs.
Yang CW, Cho YT, Chen KL, Chen YC, Song HL, Chu CY. Long-term Sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Acta Derm Venereol. 2016;96(4):525-9. https://doi.org/f8nzxw.
Ramchandani M, Kong M, Tronstein E, Selke S, Mikhaylova A, Magaret A, et al. Herpes Simplex Virus Type 1 Shedding in Tears and Nasal and Oral Mucosa of Healthy Adults. Sex Transm Dis. 2016;43(12):756-60. https://doi.org/f9cq7h.
Centers for Disease Control and Prevention (CDC). Genital herpes - Detailed Fact Sheet. Washington D. C.: CDC; 2017 [cited 2020 Apr 10]. Available from: https://bit.ly/32sxiln.
Dimensions
PlumX
Visitas a la página del resumen del artículo
Descargas
Cómo citar
Licencia
Derechos de autor 2021 Revista de la Facultad de Medicina

Esta obra está bajo una licencia Creative Commons Reconocimiento 3.0 Unported.
-








